drugset / Trial / NCT02112812

Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease

NCT02112812

Completed 82 enrolled National University of Malaysia
NaSingle-groupOpen-labelTreatment

Summary

A higher prevalence of Helicobacter pylori infection rate has been demonstrated among PD patients compared to controls. As H. pylori infection is known to interfere with levodopa absorption, we embarked on this is a study to understand the effects of Helicobacter pylori infection eradication among a selected Malaysian population with Parkinsons disease, in relation to levodopa effectiveness and motor improvements. The study hypotheses are: 1. H. pylori eradication improves L-dopa 'onset' time and prolongs the L-dopa 'on-time' duration. 2. PD patients with H. pylori infection show clinical improvement in motor disability and quality of life after eradication therapy of H. pylori, assessed using UPDRS-III / PDQ39 questionnaires.

Timeline

Start
2012-12
Primary completion
2013-03
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg Oral
Subject Clarithromycin Small molecule 500 mg Oral
Subject Esomeprazole Small molecule 40 mg Oral

Indications

No indication recorded.